Opportunity Information: Apply for RFA NS 24 027

The National Institutes of Health (NIH) is offering a discretionary research grant opportunity titled "VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)," under funding opportunity number RFA-NS-24-027. The mechanism is an R01 research project grant, and it is explicitly designated as "Clinical Trial Not Allowed," meaning applicants must propose non-clinical-trial research activities (for example, basic, translational, methodological, or observational work that does not meet NIH's definition of a clinical trial). The scientific theme signaled by the title is vascular contributions to cognitive impairment and dementia (VCID), with a specific emphasis on small vessel cerebrovascular disease mechanisms in the context of Alzheimer’s disease and related dementias (ADRD). The framing as a "Center Without Walls" typically implies a coordinated, collaborative, multi-team effort that functions like a center but is not constrained to a single physical location, encouraging networked projects, shared resources, and cross-institution coordination to accelerate progress in the field.

From a funding classification standpoint, the opportunity falls under the Health funding activity category and is associated with CFDA numbers 93.853 and 93.866. The agency administering the program is NIH, and the listed application due date (original closing date) is February 1, 2024. The notice shows an award ceiling of $1,000,000, which indicates the maximum award amount permitted under this opportunity (actual award size can vary based on the proposed scope and NIH program expectations). The source text does not specify the number of expected awards, leaving that element unclear in the provided data.

A wide range of applicant organizations are eligible. Eligible domestic applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and other Native American tribal organizations that are not federally recognized tribal governments. The eligibility list also includes public housing authorities and Indian housing authorities. Nonprofit organizations are eligible whether or not they hold 501(c)(3) status, as long as they are not institutions of higher education under that classification, and for-profit organizations are also eligible (other than small businesses), along with small businesses. In addition, the opportunity highlights several categories often emphasized in NIH participation and capacity-building efforts, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions (Asian American and Native American Pacific Islander Serving Institutions), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible agencies of the federal government, regional organizations, and applicants located in a U.S. territory or possession.

There are important limits on foreign involvement. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) foreign institutions are stated as not eligible to apply as applicant organizations. Likewise, non-domestic components of U.S. organizations are not eligible to apply. However, the opportunity allows "foreign components" as defined in the NIH Grants Policy Statement. In practice, that means a U.S.-based applicant organization may include certain well-justified international elements within the project (such as specific collaborations, resources, or activities conducted abroad) when they meet NIH's definition of a foreign component and are properly disclosed and approved, even though a foreign institution cannot serve as the primary applicant.

The program’s description is listed as "TBD" in the provided source, so the detailed requirements, required components, and review priorities are not included in your text. Even so, the title and the R01 "Center Without Walls" framing strongly suggest NIH is seeking applications that integrate expertise across disciplines relevant to small vessel cerebrovascular disease and ADRD, likely emphasizing collaboration, shared approaches or platforms, and research that can clarify mechanisms and identify leverage points for prevention, diagnosis, or treatment development, without conducting a clinical trial. For full specifics, applicants would normally rely on the complete Funding Opportunity Announcement text for required aims, allowable costs, project period expectations, whether multiple PD/PI leadership is encouraged, data sharing expectations, and any mandated consortium or coordination elements implied by the "without walls" center concept.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
  • This funding opportunity was created on 2023-08-16.
  • Applicants must submit their applications by 2024-02-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA NS 24 027

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH RFA-NS-24-027 (R01) - VCID Center Without Walls for Small Vessel Cerebrovascular Disease Mechanisms in ADRD (Clinical Trial Not Allowed)

1) What is the official title of this NIH grant opportunity?

The opportunity is titled "VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)."

2) What is the funding opportunity number?

The funding opportunity number is RFA-NS-24-027.

3) Which federal agency is offering this opportunity?

The administering agency is the National Institutes of Health (NIH).

4) What type of grant mechanism is being used?

This is an R01 Research Project Grant mechanism.

5) Does this opportunity allow clinical trials?

No. It is explicitly designated as "Clinical Trial Not Allowed," meaning the proposed work must not meet NIH's definition of a clinical trial.

6) What kinds of research activities fit under "Clinical Trial Not Allowed" based on the information provided?

The provided information indicates applicants should propose non-clinical-trial research activities such as basic, translational, methodological, or observational work, as long as the project does not meet NIH's definition of a clinical trial.

7) What scientific topic area does this opportunity focus on?

The scientific theme is vascular contributions to cognitive impairment and dementia (VCID), with emphasis on small vessel cerebrovascular disease mechanisms in the context of Alzheimer's disease and related dementias (ADRD).

8) What does "VCID" refer to in the context of this opportunity?

VCID refers to "vascular contributions to cognitive impairment and dementia."

9) What does "ADRD" mean?

ADRD stands for "Alzheimer's disease and related dementias."

10) What is meant by a "Center Without Walls" in this funding opportunity?

Based on the information provided, a "Center Without Walls" typically implies a coordinated, collaborative, multi-team effort that operates like a center but is not limited to a single physical location. It generally supports networked projects, shared resources, and cross-institution coordination to accelerate progress.

11) What funding activity category is associated with this opportunity?

The opportunity falls under the Health funding activity category.

12) Which CFDA numbers are associated with this grant opportunity?

The opportunity is associated with CFDA numbers 93.853 and 93.866.

13) What is the application due date listed in the provided information?

The listed application due date (original closing date) is February 1, 2024.

14) What is the maximum award amount (award ceiling) stated for this opportunity?

The notice shows an award ceiling of $1,000,000, indicating the maximum award amount permitted under this opportunity. Actual award size may vary depending on scope and NIH expectations.

15) How many awards does NIH expect to make under this opportunity?

The number of expected awards is not specified in the provided information.

16) Are U.S. state and local government entities eligible to apply?

Yes. Eligible domestic applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.

17) Are U.S. colleges and universities eligible to apply?

Yes. Eligibility includes public and state-controlled institutions of higher education and private institutions of higher education.

18) Are tribal governments or tribal organizations eligible to apply?

Yes. Eligibility includes federally recognized Native American tribal governments, as well as other Native American tribal organizations that are not federally recognized tribal governments.

19) Are public housing authorities eligible?

Yes. The eligibility list includes public housing authorities and Indian housing authorities.

20) Are nonprofit organizations eligible to apply?

Yes. Nonprofit organizations are eligible whether or not they have 501(c)(3) status, as long as they are not institutions of higher education under that classification.

21) Are for-profit organizations eligible to apply?

Yes. For-profit organizations are eligible (other than small businesses), and small businesses are also listed as eligible.

22) Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are specifically highlighted as eligible within the categories listed.

23) Are federally owned or operated entities eligible to apply?

Yes. The eligibility list includes eligible agencies of the federal government.

24) Are applicants located in U.S. territories or possessions eligible?

Yes. The opportunity includes applicants located in a U.S. territory or possession.

25) Are Historically Black Colleges and Universities (HBCUs) and other minority-serving institutions eligible?

Yes. The opportunity highlights multiple institution types, including HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and AANAPISI institutions.

26) Can a non-U.S. (foreign) organization apply as the primary applicant?

No. Non-domestic (non-U.S.) entities and non-domestic foreign institutions are stated as not eligible to apply as applicant organizations.

27) Can a non-domestic component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are not eligible to apply as applicant organizations.

28) Are any international activities allowed within a project?

Yes, the opportunity allows "foreign components" as defined in the NIH Grants Policy Statement. This means a U.S.-based applicant organization may include certain well-justified international elements within the project when they meet NIH's definition of a foreign component and are properly disclosed and approved.

29) If foreign institutions cannot apply, what does allowing a "foreign component" practically imply?

Based on the information provided, it implies that a U.S.-based applicant may include specific collaborations, resources, or activities conducted abroad within the project when justified and consistent with NIH policy, even though a foreign institution cannot serve as the primary applicant.

30) Is the detailed program description available in the provided information?

No. The program description is listed as "TBD" in the provided source, so detailed requirements, required components, and review priorities are not included here.

31) What can applicants infer about the likely scientific direction given the title and "Center Without Walls" framing?

From the title and framing alone, it suggests NIH is interested in applications that integrate expertise across disciplines related to small vessel cerebrovascular disease and ADRD, likely emphasizing collaboration, shared approaches or platforms, and research that clarifies mechanisms and identifies leverage points for prevention, diagnosis, or treatment development, without conducting a clinical trial.

32) Where would applicants typically look for specifics not included in the provided summary?

Applicants would normally rely on the full Funding Opportunity Announcement (FOA) text for details such as required aims, allowable costs, project period expectations, whether multiple PD/PI leadership is encouraged, data sharing expectations, and any required consortium or coordination elements implied by the "Center Without Walls" concept.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Sustaining Impact for Youth Activity

Previous opportunity: Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA NS 24 027

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA NS 24 027) also looked into and applied for these:

Funding Opportunity
NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030

Funding Number: RFA NS 23 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290

Funding Number: PA 23 290
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291

Funding Number: PA 23 291
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274

Funding Number: PAR 23 274
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046

Funding Number: RFA AG 24 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162

Funding Number: RFA MH 24 162
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027

Funding Number: RFA AG 24 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012

Funding Number: RFA RM 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002

Funding Number: RFA HG 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031

Funding Number: RFA AG 24 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030

Funding Number: RFA AG 24 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,750,000
Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003

Funding Number: RFA DE 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Apply for PAR 22 268

Funding Number: PAR 22 268
Agency: National Institutes of Health
Category: Health
Funding Amount: $325,000
Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 055

Funding Number: RFA AI 23 055
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 004

Funding Number: RFA DE 24 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 24 005

Funding Number: RFA DE 24 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) Apply for RFA MH 25 145

Funding Number: RFA MH 25 145
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional) Apply for PAR 23 241

Funding Number: PAR 23 241
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,300,000
IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) Apply for PAR 23 257

Funding Number: PAR 23 257
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) Apply for RFA MH 25 125

Funding Number: RFA MH 25 125
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 24 027", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: